| Literature DB >> 29734997 |
Seema Khosla1, Maryann C Deak2, Dominic Gault3, Cathy A Goldstein4, Dennis Hwang5, Younghoon Kwon6, Daniel O'Hearn7, Sharon Schutte-Rodin8, Michael Yurcheshen9, Ilene M Rosen8, Douglas B Kirsch10, Ronald D Chervin4, Kelly A Carden11, Kannan Ramar12, R Nisha Aurora13, David A Kristo14, Raman K Malhotra15, Jennifer L Martin16,17, Eric J Olson12, Carol L Rosen18, James A Rowley19.
Abstract
ABSTRACT: Consumer sleep technologies (CSTs) are widespread applications and devices that purport to measure and even improve sleep. Sleep clinicians may frequently encounter CST in practice and, despite lack of validation against gold standard polysomnography, familiarity with these devices has become a patient expectation. This American Academy of Sleep Medicine position statement details the disadvantages and potential benefits of CSTs and provides guidance when approaching patient-generated health data from CSTs in a clinical setting. Given the lack of validation and United States Food and Drug Administration (FDA) clearance, CSTs cannot be utilized for the diagnosis and/or treatment of sleep disorders at this time. However, CSTs may be utilized to enhance the patient-clinician interaction when presented in the context of an appropriate clinical evaluation. The ubiquitous nature of CSTs may further sleep research and practice. However, future validation, access to raw data and algorithms, and FDA oversight are needed.Entities:
Keywords: consumer sleep technology; patient-generated health data (PGHD); polysomnography
Mesh:
Year: 2018 PMID: 29734997 PMCID: PMC5940440 DOI: 10.5664/jcsm.7128
Source DB: PubMed Journal: J Clin Sleep Med ISSN: 1550-9389 Impact factor: 4.062